Singular Genomics Systems, Granted U.S. Patent: #11773439: Nucleic acid sequencing-by-synthesis (SBS) methods that combine SBS cycle steps
Portfolio Pulse from Charles Gross
Singular Genomics Systems has been granted U.S. Patent #11773439 for its nucleic acid sequencing-by-synthesis (SBS) methods that combine SBS cycle steps. The patent could potentially strengthen the company's intellectual property portfolio and competitive position in the genomics market.
October 03, 2023 | 4:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Singular Genomics Systems, listed as OMIC, has been granted a new patent. This could potentially enhance the company's competitive edge in the genomics market.
The granting of a new patent to Singular Genomics Systems could potentially enhance its intellectual property portfolio and strengthen its competitive position in the genomics market. This could have a positive impact on the company's stock in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100